Cannabinoids, electrophysiology, and retrograde messengers: Challenges for the next 5 years

Journal Title: The AAPS Journal - Year 2006, Vol 8, Issue 2

Abstract

Most of the behavioral effects of cannabis and its active ingredients, the cannabinoids (Δ9THC being the most abundant of these), appear to be mediated by cannabinoid receptors. Endogenous cannabinoids (endocannabinoids) are lipid mediators that activate these same cannabinoid receptors. Elegant work from several laboratories over the past 5 years has established that endocannabinoids, possibly acting as retrograde messengers, mediate several forms of neuronal plasticity. Endocannabinoid-mediated neuronal plasticity is common, apparently occurring at all neurons that express cannabinoid receptors. Thus, it is likely that, Δ9THC produces its effects by interacting with endocannabinoidmediated neuronal plasticity, though whether it does so cooperatively or antagonistically remains an open question. In this review we will briefly discuss the work establishing endocannabinoids as mediators of neuronal plasticity and then present evidence that a major effect of Δ9THC may be to antagonize the actions of endocannabinoids.

Authors and Affiliations

Alex Straiker, Ken Mackie

Keywords

Related Articles

Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World’s Top Oral Drugs

The Biopharmaceutics Classification System (BCS) categorizes drugs into one of four biopharmaceutical classes according to their water solubility and membrane permeability characteristics and broadly allows the predictio...

Role of Glycosylation in Conformational Stability, Activity, Macromolecular Interaction and Immunogenicity of Recombinant Human Factor VIII

Factor VIII (FVIII) is a multi-domain glycoprotein that is an essential cofactor in the blood coagulation cascade. Its deficiency or dysfunction causes hemophilia A, a bleeding disorder. Replacement using exogenous recom...

Challenges and Opportunities in Achieving Bioequivalence for Fixed-Dose Combination Products

Fixed-dose combination (FDC) products are becoming a popular treatment option because of increased patient compliance and convenience, improved clinical effectiveness, and reduced cost to the patient, among several other...

A novel in vitro release method for submicron-sized dispersed systems

Sink conditions are often violated when using conventional release methods for dispersed systems. A novel reverse dialysis bag method was designed to overcome this problem. Model drug transport rates from submicron emuls...

Informatic Tools and Approaches in Postmarketing Pharmacovigilance Used by FDA

The safety profile of newly approved drugs and therapeutic biologics is less well developed by pre-marketing clinical testing than is the efficacy profile. The full safety profile of an approved product is established du...

Download PDF file
  • EP ID EP681778
  • DOI  10.1007/BF02854897
  • Views 94
  • Downloads 0

How To Cite

Alex Straiker, Ken Mackie (2006). Cannabinoids, electrophysiology, and retrograde messengers: Challenges for the next 5 years. The AAPS Journal, 8(2), -. https://europub.co.uk/articles/-A-681778